August 05, 2020 – Medtronic plc (Dublin, Ireland) announced that its recently FDA-approved InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy is now available in the U.S. Cleveland Clinic performed the first patient implant in the nation with the new device.
At 2.8 cm, the device is 50% smaller than the market’s other rechargeable SNM device, making it the world’s smallest, the company says.
Additional features of the device include:
- Allows patients to choose how and when they want to charge their device —from a quick charge once a week, or as infrequent as once per month, depending on the patient’s preference or device settings.
- Features SureScan MRI technology, which enables full-body MRI conditional scans.
- Does not require impedance checks prior to an MRI scan, providing more efficiency in patient care versus the other SNM system on the market.
- Can recharge from zero to 100% in less than an hour, making it the fastest battery available.
- Reduces the need for battery replacement surgeries due to its life of 15 years.